Bongkrekic acid is a mitochondrial permeability transition pore blocker that acts as an inhibitory ligand of the mitochondrial adenine nucleotide translocator. This compound has been shown to inhibit apoptosis by preventing PARP cleavage and DEVDase activity.
1. Yoon, H.S., et al. 2000. Biochem Bioph Res Comun. 276:151-156. PMID: 11006098
2. Zamora, M., et al. 2004. FEBS Letters. 563:155-160. PMID: 15063741
See how others have used Bongkrekic acid (CAS 11076-19-0). Click on the entry to view the PubMed entry .
PMID: # 29415987 Zhou, C. et al. 2018. Cell Death Dis. 9: 161.
PMID: # 25889084 Sulaiman, MK. et al. 2015. Mol. Cancer. 14: 78.
PMID: # 32821888 Photochem. Photobiol. Sci.
PMID: # 32291414 Oncogene. 4257-4270.
PMID: # 22272225 PLoS One. e28694.
PMID: # 32423794 Biochem. Biophys. Res. Commun.
PMID: # 26388407 Chem Biol Interact. 51-60.
PMID: # 32143825 Biochem. Biophys. Res. Commun.
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2021 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.